openPR Logo
Press release

Exosome Diagnostic Market 2024 Trends : Projected to Grow at a CAGR of 8.6% by 2032 | NX Pharmagen, Aethlon Medical, Sistemic Inc.

02-06-2024 12:20 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Exosome Diagnostic Market 2024 Trends : Projected to Grow at

According to the report, the global exosome diagnostic and therapeutic industry was estimated at $224.34 million in 2020, and is anticipated to hit $2.9 billion by 2030, registering a CAGR of 29.4% from 2021 to 2030.

Key players in the industry:

Exosome Diagnostics Inc.
NanoSomix Inc.
Thermo Fisher Scientific Inc.
Malvern Instruments Ltd.
System Biosciences Inc.
NX Pharmagen
Aethlon Medical, Inc.
Sistemic Inc.

Request Sample Copy of the Report:

https://www.alliedmarketresearch.com/request-sample/1723

Key Takeaways:

The diagnostic segment to dominate by 2030.

The instrument segment to maintain the lion's share.

Software segment Enterprises segment was the highest revenue contributor during the forecast period.

Market Segmentation:

Product type:

Exosome isolation kits: Exosome isolation kits are used to isolate exosomes from biological samples, such as blood, urine, and saliva.
Exosome detection kits: Exosome detection kits are used to detect exosomes in biological samples.
Exosome diagnostic assays: Exosome diagnostic assays are used to detect and quantify specific exosome biomarkers associated with different diseases.
Application:

Cancer: Exosome diagnostic tests are being developed for a wide range of cancers, including lung cancer, breast cancer, and pancreatic cancer.
Neurodegenerative diseases: Exosome diagnostic tests are being developed for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.
Infectious diseases: Exosome diagnostic tests are being developed for infectious diseases, such as COVID-19 and HIV.
Other applications: Exosome diagnostic tests are also being developed for other diseases, such as cardiovascular disease and autoimmune diseases.
End user:

Hospitals: Hospitals are the largest users of exosome diagnostic tests.
Reference laboratories: Reference laboratories also use exosome diagnostic tests to provide testing services to hospitals and clinics.
Research laboratories: Research laboratories use exosome diagnostic tests to develop new exosome biomarkers and to study the role of exosomes in disease.
Geography:

North America: North America is the largest market for exosome diagnostic tests.
Europe: Europe is the second-largest market for exosome diagnostic tests.
Asia Pacific: Asia Pacific is the fastest-growing market for exosome diagnostic tests.
Request for Customization - https://www.alliedmarketresearch.com/request-for-customization/1723

Increase in use of multifunctional property of exosome therapy for chronic heart failure, Alzheimer's disease, Parkinson's disease, and cancer drive the growth of the global exosome diagnostic and therapeutic market. On the other hand, rise in demand for drug therapies and surge in R&D activities in the pharmaceutical and biopharmaceutical fields supplement the market growth even more. Moreover, surge in potential application of exosomes in cancer diagnosis and development of translational precision medicines are expected to create lucrative opportunities in the industry.

Regional Growth Dynamics:

North America held the major share in 2020, generating nearly two-fifths of the global exosome diagnostic and therapeutic market, due to rise in product launches for exosome therapeutics, surge in the presence of key players, and development of R&D activities in the pharmaceutical and biopharmaceutical sector across the province. Asia-Pacific, however, would grow at the fastest CAGR of 30.3% by 2030. Increase in the prevalence of chronic and infectious disorders, growth in health care expenditures, and surge in demand for molecular diagnosis drive the market growth in the region.

Buy this Premium Research Report:

https://www.alliedmarketresearch.com/purchase-enquiry/1723

Recent developments:

New exosome isolation and detection methods: New methods for isolating and detecting exosomes are being developed that are more sensitive, specific, and efficient. This is leading to the development of more accurate and reliable exosome diagnostic tests.

Exosome-based liquid biopsies: Exosome-based liquid biopsies are a type of non-invasive biopsy that can be used to detect and monitor diseases by analyzing exosomes in blood or other bodily fluids. Exosome-based liquid biopsies are becoming increasingly popular, as they are less invasive and more convenient than traditional biopsies.

Browse more latest healthcare reports:

Medical Implants Market https://www.alliedmarketresearch.com/medical-implants-market

Ostomy Drainage Bags Market https://www.alliedmarketresearch.com/ostomy-drainage-bags-market

Analgesics Market https://www.alliedmarketresearch.com/analgesics-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Exosome Diagnostic Market 2024 Trends : Projected to Grow at a CAGR of 8.6% by 2032 | NX Pharmagen, Aethlon Medical, Sistemic Inc. here

News-ID: 3374246 • Views:

More Releases from Allied Market Research

Fan Market is Poised to Surpass US$ 16.9 Billion by 2031, Showcasing a CAGR of 4.3% From 2022 to 2031
Fan Market is Poised to Surpass US$ 16.9 Billion by 2031, Showcasing a CAGR of 4 …
According to a new report published by Allied Market Research, titled, "Fan Market by Product Type, by End User, by Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2022-2031". The report offers an exhaustive examination of prime investment opportunities, successful strategies, key drivers, potential openings, market size projections, competitive dynamics, and evolving market trends. Download Sample Report @https://www.alliedmarketresearch.com/request-sample/12770 Innovations in fan technology, such as energy-efficient designs, smart features, and improved materials, can
Cosmetics Face Serum Market Share Reach US$ 5.6 Billion by 2031, Key Factors Behind Industry Growth
Cosmetics Face Serum Market Share Reach US$ 5.6 Billion by 2031, Key Factors Beh …
According to a new report published by Allied Market Research, titled, "Cosmetics Face Serum Market by Product Type, by Price Point, by Gender, by Application, by Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031". The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends. The global cosmetics face serum market size was
MICE Industry to See Stunning Growth: $2,309.4 Billion with a CAGR of 11.6% From 2023 to 2032
MICE Industry to See Stunning Growth: $2,309.4 Billion with a CAGR of 11.6% From …
According to a new report published by Allied Market Research, titled, "MICE Industry by Event Type (Meeting, Incentive, Conventions, and Exhibitions): Global Opportunity Analysis and Industry Forecast 2021-2031 Market," The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends. Download Sample Report @https://www.alliedmarketresearch.com/request-sample/2433 Social media is very influential on society in both positive and negative
Pet Training Services Market Share Reach US$ 6.84 Billion by 2031, Key Factors Behind Industry Growth
Pet Training Services Market Share Reach US$ 6.84 Billion by 2031, Key Factors B …
According to a new report published by Allied Market Research, titled, "Pet Training Services Market by Pet Type, by Purpose, by Branch, by Training Method: Global Opportunity Analysis and Industry Forecast, 2021-2031". The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends. The global pet training services market size was valued at $3.83

All 5 Releases


More Releases for Exosome

Emerging Trends Exosome Diagnostics and Therapeutics Market Dominated by Evox Th …
An exosome diagnostic and therapeutic study approach represents the opportunity to expand and develop the liquid biopsy market, a growing sector in cancer diagnostics. Once they reach the recipient cells, cytoplasmic ingredients can alter their biology. Access Sample Papers of Exosome Diagnostics and Therapeutics Market with 248 Pages and 6 Company Profiles Now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1529771 . Growth in exosome diagnostic and therapeutic market in these regions attributes to the technological advancement in
Exosome Diagnostic Market 2025 SWOT Analysis by Top Key Players-Aethlon Medical, …
Exosome Diagnostic Software market size estimations have been provided in terms of value (USD million). The Global Exosome Diagnostic Software industry report also identifies major market players and provides analysis in terms of company overview, financials, products & services, market trends, recent developments and growth strategies. Get Sample Copy of this Report @ https://www.orianresearch.com/request-sample/566927 Exosome Diagnostic Market report offers a comprehensive insight into the development policies and plans in addition to manufacturing
Exosome Diagnostic and Therapeutic Market is expected to reach $368 million by 2 …
Exosome Diagnostic and Therapeutic Market was valued at $39 million, and is expected to reach $368 million by 2022, supported by a CAGR of 37.8%. Exosomes play a key role in facilitating cell-to-cell communication in the cancer prognosis. It suppresses the immune function by inducing apoptosis of activated cytotoxic T cells, which enable tumor progression in the human body. In addition, exosomes also stimulate the angiogenesis and migration leading to
Exosome Diagnostic and Therapeutic Market – Qualitative Outlook On Growth 2025 …
Global Exosome Diagnostic and Therapeutic Market: Snapshot The demand for diagnostic and therapeutic of exosome is projected to increment at a substantial CAGR during the forecast period of 2016 to 2024, gaining traction from a number of factors such as increasing prevalence of cancer, technological advancements in exosome isolation and pertaining analytical procedures, multiple awareness initiatives implemented by the government and healthcare organizations in various developed and emerging economies, and innovative
Exosome Diagnostic and Therapeutic Market key players 2016 - 2024 : System Biosc …
Global Exosome Diagnostic and Therapeutic Market: Snapshot The demand for diagnostic and therapeutic of exosome is projected to increment at a substantial CAGR during the forecast period of 2016 to 2024, gaining traction from a number of factors such as increasing prevalence of cancer, technological advancements in exosome isolation and pertaining analytical procedures, multiple awareness initiatives implemented by the government and healthcare organizations in various developed and emerging economies, and innovative
Exosome Diagnostic and Therapeutics Market Size By 2027 | Thermo Fisher Scientif …
Future Market Insights in its recent research report titled “Exosome Diagnostic and Therapeutics Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” covers several factors that are influencing the robust growth of the global market. As per this research report, the global exosome diagnostic and therapeutic market is projected to expand at a high CAGR of 23.1% during the period of assessment. The exhaustive research publication includes key trends, opportunities,